986 related articles for article (PubMed ID: 25849134)
1. Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes.
Caruana I; Savoldo B; Hoyos V; Weber G; Liu H; Kim ES; Ittmann MM; Marchetti D; Dotti G
Nat Med; 2015 May; 21(5):524-9. PubMed ID: 25849134
[TBL] [Abstract][Full Text] [Related]
2. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
[TBL] [Abstract][Full Text] [Related]
3. K562-Derived Whole-Cell Vaccine Enhances Antitumor Responses of CAR-Redirected Virus-Specific Cytotoxic T Lymphocytes In Vivo.
Caruana I; Weber G; Ballard BC; Wood MS; Savoldo B; Dotti G
Clin Cancer Res; 2015 Jul; 21(13):2952-62. PubMed ID: 25691731
[TBL] [Abstract][Full Text] [Related]
4. [Human heparanase: roles in invasion and metastasis of cancer].
Gohji K; Katsuoka Y; Okamoto M; Kamidono S; Kitazawa S; Toyoshima M; Dong J; Nakajima M
Hinyokika Kiyo; 2000 Oct; 46(10):757-62. PubMed ID: 11215206
[TBL] [Abstract][Full Text] [Related]
5. Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma.
Chmielewski M; Hombach AA; Abken H
Immunol Rev; 2014 Jan; 257(1):83-90. PubMed ID: 24329791
[TBL] [Abstract][Full Text] [Related]
6. Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.
Parish CR; Freeman C; Ziolkowski AF; He YQ; Sutcliffe EL; Zafar A; Rao S; Simeonovic CJ
Matrix Biol; 2013 Jun; 32(5):228-33. PubMed ID: 23499527
[TBL] [Abstract][Full Text] [Related]
7. Heparanase of murine effector lymphocytes and neutrophils is not required for their diapedesis into sites of inflammation.
Stoler-Barak L; Petrovich E; Aychek T; Gurevich I; Tal O; Hatzav M; Ilan N; Feigelson SW; Shakhar G; Vlodavsky I; Alon R
FASEB J; 2015 May; 29(5):2010-21. PubMed ID: 25634957
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Heparanase in Pediatric Brain Tumor Cells Attenuates their Proliferation, Invasive Capacity, and
Spyrou A; Kundu S; Haseeb L; Yu D; Olofsson T; Dredge K; Hammond E; Barash U; Vlodavsky I; Forsberg-Nilsson K
Mol Cancer Ther; 2017 Aug; 16(8):1705-1716. PubMed ID: 28716813
[TBL] [Abstract][Full Text] [Related]
9. Heparanase antisense suppression of A-549 lung carcinoma invasion.
Peng C; Ren P; Zhou Q; Sun Q; Zhao X; Cong B
Asian Pac J Cancer Prev; 2011; 12(12):3371-4. PubMed ID: 22471483
[TBL] [Abstract][Full Text] [Related]
10. Antisense-mediated suppression of Heparanase gene inhibits melanoma cell invasion.
Roy M; Reiland J; Murry BP; Chouljenko V; Kousoulas KG; Marchetti D
Neoplasia; 2005 Mar; 7(3):253-62. PubMed ID: 15799825
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity.
Lider O; Mekori YA; Miller T; Bar-Tana R; Vlodavsky I; Baharav E; Cohen IR; Naparstek Y
Eur J Immunol; 1990 Mar; 20(3):493-9. PubMed ID: 2318247
[TBL] [Abstract][Full Text] [Related]
12. Regulation of mouse Heparanase gene expression in T lymphocytes and tumor cells.
de Mestre AM; Soe-Htwe T; Sutcliffe EL; Rao S; Pagler EB; Hornby JR; Hulett MD
Immunol Cell Biol; 2007; 85(3):205-14. PubMed ID: 17213834
[TBL] [Abstract][Full Text] [Related]
13. Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor.
Pameijer CR; Navanjo A; Meechoovet B; Wagner JR; Aguilar B; Wright CL; Chang WC; Brown CE; Jensen MC
Cancer Gene Ther; 2007 Jan; 14(1):91-7. PubMed ID: 17024231
[TBL] [Abstract][Full Text] [Related]
14. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.
Kelly T; Suva LJ; Huang Y; Macleod V; Miao HQ; Walker RC; Sanderson RD
Cancer Res; 2005 Jul; 65(13):5778-84. PubMed ID: 15994953
[TBL] [Abstract][Full Text] [Related]
15. Transfection of antisense oligodeoxynucleotide inhibits heparanase gene expression and invasive ability of human pancreatic cancer cell in vitro.
Gao J; Su L; Qin R; Chang Q; Huang T; Feng Y
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(1):72-4. PubMed ID: 16711012
[TBL] [Abstract][Full Text] [Related]
16. Anti-GD3 chimeric sFv-CD28/T-cell receptor zeta designer T cells for treatment of metastatic melanoma and other neuroectodermal tumors.
Lo AS; Ma Q; Liu DL; Junghans RP
Clin Cancer Res; 2010 May; 16(10):2769-80. PubMed ID: 20460472
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of CAR T-cell therapy in large tumors relies upon stromal targeting by IFNγ.
Textor A; Listopad JJ; Wührmann LL; Perez C; Kruschinski A; Chmielewski M; Abken H; Blankenstein T; Charo J
Cancer Res; 2014 Dec; 74(23):6796-805. PubMed ID: 25297631
[TBL] [Abstract][Full Text] [Related]
18. Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumors.
Abken H
Immunotherapy; 2015; 7(5):535-44. PubMed ID: 26065478
[TBL] [Abstract][Full Text] [Related]
19. Coexpressed Catalase Protects Chimeric Antigen Receptor-Redirected T Cells as well as Bystander Cells from Oxidative Stress-Induced Loss of Antitumor Activity.
Ligtenberg MA; Mougiakakos D; Mukhopadhyay M; Witt K; Lladser A; Chmielewski M; Riet T; Abken H; Kiessling R
J Immunol; 2016 Jan; 196(2):759-66. PubMed ID: 26673145
[TBL] [Abstract][Full Text] [Related]
20. T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivo.
Geldres C; Savoldo B; Hoyos V; Caruana I; Zhang M; Yvon E; Del Vecchio M; Creighton CJ; Ittmann M; Ferrone S; Dotti G
Clin Cancer Res; 2014 Feb; 20(4):962-71. PubMed ID: 24334762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
